Epidemiology and Economic Burden of Osteoporosis in Malta

被引:0
|
作者
Ivergard, Moa [1 ]
Svedbom, Axel [1 ]
Hernlund, Emma [1 ]
Compston, Juliet [2 ]
Cooper, Cyrus [3 ,4 ]
Stenmark, Judy [5 ]
McCloskey, Eugene V. [6 ,7 ]
Jonsson, Bengt [8 ]
Galea, Raymond P. [9 ]
Kanis, John A. [7 ,10 ]
机构
[1] OptumInsight, Stockholm, Sweden
[2] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England
[3] Univ Southampton, MRC Lifewurse Epidemiol Unit, Southampton, Hants, England
[4] Univ Oxford, Inst Musculoskeletal Sci, NIHR Musculoskeletal Biomed Res Unit, Oxford, England
[5] Int Osteoporosis Fdn, Nyon, Switzerland
[6] No Gen Hosp, Acad Unit Bone Metab, Sheffield S5 7AU, S Yorkshire, England
[7] Univ Sheffield, WHO Collaborating Ctr Metab Bone Dis, Sheffield S10 2RX, S Yorkshire, England
[8] Stockholm Sch Econ, S-11383 Stockholm, Sweden
[9] Mater Dei Hosp, Dept Obstet & Gynaecol, Msida, Malta
[10] Univ Sheffield, WHO Collaborating Ctr Metab Bone Dis, Sch Med, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This report describes epidemiology, burden, and treatment of osteoporosis in Malta. Introduction Osteoporosis is characterized by reduced bone mass and disruption of bone architecture, resulting in increased risks of fragility fractures which represent the main clinical consequence of the disease. Fragility fractures are associated with substantial pain and suffering, disability and even death for the affected patients and substantial costs to society. The aim of this study is to describe the epidemiology and economic burden of fragility fractures as a consequence of osteoporosis in Malta, as a further detailed addition to the report for the entire European Union (EU27): Osteoporosis in the European Union: Medical Management, Epidemiology and Economic Burden. Methods The literature on fracture incidence and costs of fractures in Malta was reviewed and incorporated into a model estimating the clinical and economic burden of osteoporotic fractures in 2010. Furthermore, data on sales of osteoporosis treatments and the population at high risk were used to estimate treatment uptake and treatment gap. Results It was estimated that approximately 2,600 new fragility fractures were sustained in Malta, comprising 450 hip fractures, 430 vertebral fractures, 470 forearm fractures and 1,300 other fractures (i.e. fractures of the pelvis, rib, humerus, tibia, fibula, clavicle, scapula, sternum and other femoral fractures) in 2010. The economic burden of incident and previous fragility fractures was estimated at (sic) 17 million for the same year. Incident fractures represented 65 % of this cost, long-term fracture care 24 % and pharmacological prevention 12 %. Previous and incident fractures also accounted for 800 quality-adjusted life years (QALYs) lost during 2010. When accounting for the demographic projections for 2025, the number of incident fractures was estimated at 3,800 in 2025, representing an increase of 1,100 fractures. Hip, clinical vertebral (spine), forearm and other fractures were estimated to increase by 230, 190, 140 and 580, respectively. The burden of fractures in Malta in 2025 was estimated to increase by 39 % to (sic) 24 million. Conclusions There is a high cost of osteoporosis with a substantial projected increase of the economic burden driven by aging populations, suggesting that a change in healthcare policy concerning the disease is warranted.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Epidemiology, costs, and burden of osteoporosis in Argentina, 2009
    Spivacow F.R.
    Sánchez A.
    Archives of Osteoporosis, 2010, 5 (1-2) : 1 - 6
  • [32] EPIDEMIOLOGY, COSTS AND BURDEN OF OSTEOPOROSIS IN ARGENTINA, 2009
    Spivacow, Francisco R.
    Sanchez, Ariel
    ACTUALIZACIONES EN OSTEOLOGIA, 2010, 6 (03) : 184 - 193
  • [33] Osteoporosis: Economic Burden of Disease in Italy
    Andrea Marcellusi
    Maria Assunta Rotundo
    Claudia Nardone
    Paolo Sciattella
    Simone Gazzillo
    Maurizio Rossini
    Mario Barbagallo
    Amalia Antenori
    Domenico Valle
    Francesco Saverio Mennini
    Clinical Drug Investigation, 2020, 40 : 449 - 458
  • [34] The economic burden of osteoporosis in Iran in 2020
    Ostovar, Afshin
    Mousavi, Abdoreza
    Sajjadi-Jazi, Sayed Mahmoud
    Rajabi, Marzieh
    Larijani, Bagher
    Fahimfar, Noushin
    Daroudi, Rajabali
    OSTEOPOROSIS INTERNATIONAL, 2022, 33 (11) : 2337 - 2346
  • [35] The economic burden of osteoporosis in Iran in 2020
    Afshin Ostovar
    Abdoreza Mousavi
    Sayed Mahmoud Sajjadi-Jazi
    Marzieh Rajabi
    Bagher Larijani
    Noushin Fahimfar
    Rajabali Daroudi
    Osteoporosis International, 2022, 33 : 2337 - 2346
  • [36] THE ECONOMIC BURDEN OF OSTEOPOROSIS IN IRAN IN 2017
    Fahimfar, N.
    Rajabi, M.
    Tanha, K.
    Sajjadi-Jazi, S. M.
    Nematollahi, S.
    Sanjari, M.
    Larijani, B.
    Daroudi, R.
    Ostovar, A.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S418 - S418
  • [37] REVIEWING THE ECONOMIC BURDEN OF OSTEOPOROSIS STUDIES
    Mousavi, A.
    Mansourzadeh, M. J.
    Fahimfar, N.
    Alipour, S.
    Sanjari, M.
    Khalagi, K.
    Ostovar, A.
    Daroudi, R.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S518 - S519
  • [38] Economic burden of osteoporosis: State of the art
    Johnell, O
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S3 - S4
  • [39] Osteoporosis: Economic Burden of Disease in Italy
    Marcellusi, Andrea
    Rotundo, Maria Assunta
    Nardone, Claudia
    Sciattella, Paolo
    Gazzillo, Simone
    Rossini, Maurizio
    Barbagallo, Mario
    Antenori, Amalia
    Valle, Domenico
    Mennini, Francesco Saverio
    CLINICAL DRUG INVESTIGATION, 2020, 40 (05) : 449 - 458
  • [40] Epidemiology, costs, and the economic burden of fibromyalgia
    Michael Spaeth
    Arthritis Research & Therapy, 11